Questions and Answers About the Summary of Safety and Clinical Performance Guidelines

关于安全和临床表现指南摘要的问答

2021-03-04 05:50 United Language Group

本文共781个字,阅读需8分钟

阅读模式 切换至中文

In the third and final webinar of the series with Ronald Boumans, senior consultant for regulatory affairs at Emergo by UL we learned on the importance of Summary of Safety and Clinical Performance (SSCP) guidelines. SSCP is a critical component of the European Medical Device Regulation (MDR). The SSCP is a new addition to the MDR. Article 32 of the MDR lays out requirements for creating SSCPs for all implantable medical devices. The purpose of the SSCP is for both patients and users to grasp the protocols for safety and performance of implantable Class III devices. You can review guidance in Medical Device Coordination Group (MDCG) document 2019-9. So, when is the SSCP required? The SSCP is required for all Class III devices, all implantable devices, and all Annex XVI devices. If my device isn't categorized as any of the above, am I in the clear? You don’t need to worry about the SSCP initially if your device: Is a custom-made device. Is an investigational device. Is utilized for a clinical evaluation consultation procedure and scrutiny procedures. What steps should I take to ensure that SSCP meets the expected specifications? To make sure your documentation meets these requirements, you must submit a draft of the SSCP for review and then approval by a Notified Body. Once the SSCP is approved, Notified Body will upload the document to Eudamed. The manufacturer must state on the label the instructions for using the product where the SSCP is available. For devices that fall under the scrutiny of Article 55 of the MDR, the SSCP must be included in the documents to be submitted by the Notified Body. Is all of this really necessary? While this may feel like a lot of excess work to ensure you are staying compliant, it is important to remember that the SSCP is just a summary. In the summary, there must be a Clinical Evaluation Report (CER), Periodic Safety Update Report (PSUR), and the evaluation report for post-market clinical follow-up (PMCF). All the data in the SSCP must be covered by technical documentation. What is the process for getting my SSCP approved and how often do I need to review it? Timing is an important factor when considering the SSCP. It is essential to remember that the Notified Body has to validate the SSCP. You will want to update your SSCP annually then have it reviewed by the Notified Body. Always make sure that your documents are synchronized and consistent. What content should be included in the SSCP? First, ensure you are including general information about the device and how to identify it. The next step is to give background as to the device’s intended use. Include a description of the device, risks, warnings, and some suggestions about training for users. Above all, remember that the SSCP is not intended to replace the instructions for use of your device. The SSCP should be "written in a way that is clear to the intended user and to the patients." So often, we are writing for our peers and medical professionals. Remember to consider readers of all educational levels. Physicians want to have a complete understanding of the risks and benefits of your device, and patients want to understand device complications, uses, and risks. Assume patients do not have any medical expertise. To meet the needs of all users, be sure to include lay language. For example, Patients may not understand the word "subjects." Instead, one could use "people taking part in a study." Avoid medical terms such as "the porcine valve was found non-interior to..." Instead, try, "the heart valve from a pig's heart was found to be as good as...." Above all, ensure that the translation is done properly to ensure that all member states can actually use the device. Additionally, an English translation is always required. The Notified Body will review the translations, which will then be specified through technical documentation as well as Eudamed. Make sure to write in a clear way so that the patient can really understand the device. We recommend partnering with a language expert to get this done. hbspt.cta._relativeUrls=true;hbspt.cta.load(3356907, 'ffe21457-7b73-4df6-84e2-69ec6fa983b8', {}); Life Science Language Solutions At United Language Group we pride ourselves in being industry experts, so you don’t need to take the time to bring us up to speed on regulations, industry-specific guidelines, and the strictest global requirements. We understand scientific language and processes as well as the intricacies of settings in which your translations may be used. Let’s connect. hbspt.cta._relativeUrls=true;hbspt.cta.load(3356907, '122e67c6-2df8-4340-a5e0-12671097d103', {});
在与Emergo by UL的监管事务高级顾问罗纳德.布幔斯(Ronald Boumans)举行的第三次也是最后一次网络研讨会上,我们了解到安全和临床表现(SSCP)指南摘要的重要性。安全和临床表现是欧洲医疗器械法规(MDR)的重要组成部分。 安全和临床表现指南是欧盟医疗器械法规( MDR)的新成员。《欧盟医疗器械法规》第32条规定了为所有植入式医疗器械创建安全和临床表现摘要的要求。安全和临床表现的目的是让患者和用户都掌握植入式III类设备的安全和性能的协议。您可以在医疗器械协调小组(MDCG)文件2019-9中查看指导意见。 那么,什么时候需要安全和临床表现指南呢? 所有III类设备、所有可植入设备和所有附件XVI设备都需要安全和临床表现指南。 如果我的设备没有被归类为上述任何一种,我是透明的吗? 首先,不需要担心安全和临床表现指南,如果您的设备: 是一个定制的装置。 是一个调查装置。 用于临床评估咨询程序和检查程序。 我应该采取什么步骤来确保安全和临床表现指南符合预期的规格? 为了确保您的文件符合这些要求,您必须提交一份安全和临床表现指南草案供审查,然后由一个被通知的机构批准。一旦安全和临床表现指南获得批准,通知机构将把文件上传到欧洲医疗器械数据库。制造商必须在标签上说明可使用安全和临床表现指南的产品的使用说明。对于属于《欧盟医疗器械法规》第55条审查范围的装置,必须在被通知机构提交的文件中列入安全和临床表现指南。 这一切真的有必要吗? 虽然这可能会让你觉得需要做很多多余的工作来确保一直符合要求,但记住安全和临床表现只是一个总结是很重要的。摘要中必须有临床评估报告(CER)、定期安全性更新报告(PSUR)、上市后临床随访的评估报告(PMCF)。安全和临床表现指南中的所有数据必须包含在技术文件中。 我的安全和临床表现指南获得批准的程序是什么?我需要多久审查一次? 在考虑安全和临床表现时,时机是一个重要因素。必须记住,接到通知的机构必须验证安全和临床表现指南。您希望每年更新您的安全和临床表现指南,然后由通知机构审查。始终确保您的文档是同步和一致的。 安全和临床表现指南应该包括哪些内容? 首先,确保包含有关设备以及如何识别设备的一般信息。下一步是给出设备预期用途的背景信息。包括对设备的说明、风险、警告以及有关用户培训的一些建议。最重要的是,请记住,安全和临床表现指南并不会取代您的设备的使用说明。 安全和临床表现指南应该“以一种使预期使用者和病人都清楚的方式书写。” 所以经常,我们是在为我们的同行和医学专业人士撰稿。记住要考虑所有教育水平的读者。医生希望对设备的风险和好处有一个完整的了解,患者希望了解设备的并发症,用途和风险。 假设病人没有任何医学专业知识。为了满足所有用户的需求,一定要包括外行语言。例如, 患者可能不理解“受试者”这个词。相反,人们可以用“参加研究的人”来代替。 避免使用医学术语,如“猪瓣膜被发现不在……内部”。取而代之的是,试试看,“猪心脏的心脏瓣膜被发现和……一样好。” 最重要的是,确保翻译工作得当,以确保所有会员国都能实际使用该设备。此外,英文翻译是必须的。接到通知的机构将审查翻译,然后通过技术文件和欧洲医疗器械数据库加以规定。确保以清晰的方式书写,以便患者能够真正理解该设备。我们建议与语言专家合作完成这一任务。 hbspt.cta._relativeURLS=true;hbspt.cta.load(3356907,'FFE21457-7B73-4DF6-84E2-69EC6FA983B8',{}); 生命科学语言解决方案 在联合语言集团,我们为自己是行业专家而自豪,因此您不需要花时间来使我们了解法规,特定行业的指导方针和最严格的全球要求。我们理解科学语言和过程,以及你的翻译可能使用的复杂环境。请点击链接 hbspt.cta._relativeURLS=true;hbspt.cta.load(3356907,'122E67C6-2DF8-4340-A5E0-12671097D103',{});

以上中文文本为机器翻译,存在不同程度偏差和错误,请理解并参考英文原文阅读。

阅读原文